The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION
30 September 1999 - 31 July 2005
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,341,635
(From Abstract) Molecular genetic studies of familial Alzheimer's disease (FAD) have led to the identification of three genes which, when mutated can cause Alzheimer's disease (AD); beta-amyloid precursor protein (APP) and two related genes presenilin 1 (PS1) and presenilin 2 (PS2). The normal function of each of these molecules remains unknown, however, FAD mutations in all three genes result in an increase in levels of Ab42, an amyloidogenic fragment derived from APP by proteolytic processing. The dominant inheritance of the FAD phenotype suggests that these mutations either cause a gain of function or a loss of function via a dominant negative mechanism. PS1 knock-out mice are not viable and show multiple developmental abnormalities. Neurons derived from PS1 knock-out mice show a decrease in Ab levels suggesting that PS1 is required for normal APP processing and that the FAD mutations are not loss of function alleles. Genetic experiments have demonstrated that two presenilin homologs exist in C. elegans: sel-12 and hop-1, and that these molecules undergo similar endoproteolytic processing to their mammalian counterparts. Mutations that reduce sel-12 activity or sel-12 and hop-1 activity cause phenotypes that are consistent with a reduction in signaling through the lin-12 and glp-12 (Notch homologs) pathways. The phenotype of constitutively active lin-12 mutants lacking the extracellular and transmembrane domains are not modified by reduction of sel-12 activity suggesting that the sel-12 affects Notch signaling upstream of Notch activation. PS are membrane proteins with multiple membrane spanning domains that are primarily located within the endoplasmic reticulum. To determine the normal function of PS1 we will examine Notch maturation and processing in the presence and absence of functional PS1. We will extend our observations to the effect of PS function on APP maturation and processing and finally we will examine the effect of FAD mutations on the normal function of PS1 with respect to both Notch and APP. Specifically, we hypothesize that loss of PS function leads to reduced Notch signaling and reduced Ab because PS is required for normal Notch and APP maturation within the secretory pathway. We also hypothesize that FAD-causing mutations modify the normal activity of PS1 and that this change will have no effect on Notch signaling but will subtly alter APP processing. Through these studies we hope to determine the normal function of PS1 and to gain a better understanding of the role of PS1 in AD pathogenesis. We also anticipate that these studies will increase our understanding of the Notch signaling, a process that is important not only for many developmental decisions but for cancer as well.
9 Resulting Publications
Emily S Walker; Maribel Martinez; Jun Wang; Alison GoateJournal of neurochemistry 2006;98(1):300-9.
Jun Wang; Dirk Beher; Andrew C Nyborg; Mark S Shearman; Todd E Golde; Alison GoateJournal of neurochemistry 2006;96(1):218-27.
A L Brunkan; M Martinez; J Wang; E S Walker; D Beher; M S Shearman; A M GoateJournal of neurochemistry 2005;94(5):1315-28.
Anne L Brunkan; Maribel Martinez; Emily S Walker; Alison M GoateMolecular and cellular neurosciences 2005;29(1):65-73.
A L Brunkan; M Martinez; J Wang; E S Walker; A M GoateJournal of neurochemistry 2005;92(5):1158-69.
Emily S Walker; Maribel Martinez; Anne L Brunkan; Alison GoateJournal of neurochemistry 2005;92(2):294-301.
Silva Hecimovic; Jun Wang; Georgia Dolios; Maribel Martinez; Rong Wang; Alison M GoateNeurobiology of disease 2004;17(2):205-18.
Eric H Schroeter; Ma Xenia G Ilagan; Anne L Brunkan; Silva Hecimovic; Yue-ming Li; Min Xu; Huw D Lewis; Meera T Saxena; Bart De Strooper; Archie Coonrod; et al.Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):13075-80.
R Kopan; A GoateGenes & development 2000;14(22):2799-806.
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Goate, Alison M
1 July 2005 - 30 June 2008
FOGARTY INTERNATIONAL CENTER
Total Funding: $ 117,923
Rogers, Jack T
1 August 2003 - 31 July 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,192,021
Golde, Todd E
10 April 2000 - 30 April 2009
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 2,532,291
Nodi Dehvari; Angel Cedazo-Minguez; Ola Isacsson; Tatjana Nilsson; Bengt Winblad; Helena Karlström; Eirikur Benedikz; Richard F CowburnJournal of neurochemistry 2007;102(3):848-57.
Yoshifumi Nakaya; Takuya Yamane; Hirohisa Shiraishi; Hua-Qin Wang; Etsuro Matsubara; Toru Sato; Georgia Dolios; Rong Wang; Bart De Strooper; Mikio Shoji; et al.The Journal of biological chemistry 2005;280(19):19070-7.
G Verdile; R N Martins; M Duthie; E Holmes; P H St George-Hyslop; P E FraserThe Journal of biological chemistry 2000;275(27):20794-8.
Appears in this Publication
Author of this Publication